Kiril E B van Veen1, Matthijs C Brouwer2, Arie van der Ende3, Diederik van de Beek4. 1. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands. 2. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 3. The Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 4. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: d.vandebeek@amc.uva.nl.
Abstract
OBJECTIVE: We studied occurrence, disease course, and prognosis of community-acquired bacterial meningitis in HIV-infected adults in the Netherlands. METHODS: We performed a nationwide, prospective cohort study. Patients over 16 years old with bacterial meningitis were included. Data on patient history, symptoms and signs on admission, laboratory findings, radiologic examination, treatment, and outcome were collected prospectively. For HIV-positive patients additional information was collected retrospectively. RESULTS: From March 2006 to December 2013, 1354 episodes of community-acquired meningitis were included in the cohort. Thirteen patients were HIV-infected (1.0%). The annual incidence of bacterial meningitis was 8.3-fold higher (95%CI 4.6-15.1, P < 0.001) among HIV-infected patients as compared to the general population (10.79 [95%CI 5.97-19.48] vs 1.29 [95%CI 1.22-1.37] per 100.000 patients per year). Predisposing factors (other than HIV), clinical symptoms and signs, ancillary investigations, causative organisms and outcome were comparable between HIV-infected and patients without HIV infection. CONCLUSIONS: HIV-infected patients in the Netherlands have a 8.3-fold higher risk for bacterial meningitis as compared to the general population despite cART therapy. Clinical presentation and outcome of patients with acute bacterial meningitis with and without HIV are similar.
OBJECTIVE: We studied occurrence, disease course, and prognosis of community-acquired bacterial meningitis in HIV-infected adults in the Netherlands. METHODS: We performed a nationwide, prospective cohort study. Patients over 16 years old with bacterial meningitis were included. Data on patient history, symptoms and signs on admission, laboratory findings, radiologic examination, treatment, and outcome were collected prospectively. For HIV-positivepatients additional information was collected retrospectively. RESULTS: From March 2006 to December 2013, 1354 episodes of community-acquired meningitis were included in the cohort. Thirteen patients were HIV-infected (1.0%). The annual incidence of bacterial meningitis was 8.3-fold higher (95%CI 4.6-15.1, P < 0.001) among HIV-infectedpatients as compared to the general population (10.79 [95%CI 5.97-19.48] vs 1.29 [95%CI 1.22-1.37] per 100.000 patients per year). Predisposing factors (other than HIV), clinical symptoms and signs, ancillary investigations, causative organisms and outcome were comparable between HIV-infected and patients without HIV infection. CONCLUSIONS:HIV-infectedpatients in the Netherlands have a 8.3-fold higher risk for bacterial meningitis as compared to the general population despite cART therapy. Clinical presentation and outcome of patients with acute bacterial meningitis with and without HIV are similar.
Authors: François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay Journal: Intensive Care Med Date: 2020-02-03 Impact factor: 17.440
Authors: Kiril E B van Veen; Matthijs C Brouwer; Arie van der Ende; Diederik van de Beek Journal: J Neuroimmune Pharmacol Date: 2016-09-09 Impact factor: 4.147
Authors: Laure-Amélie de Monteynard; Sophie Matheron; Sophie Grabar; Pierre de Truchis; Jacques Gilquin; Juliette Pavie; Odile Launay; Jean-Luc Meynard; Marie-Aude Khuong-Josses; David Rey; Aba Mahamat; Rosemarie Dray-Spira; Anne Simon; Dominique Costagliola; Sophie Abgrall Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240
Authors: Joseph Agossou; Chinelo Ebruke; Alphonse Noudamadjo; Julien D Adédémy; Eric Y Dènon; Honoré S Bankolé; Mariam A Dogo; Rolande Assogba; Moussa Alassane; Abdoullah Condé; Falilatou Agbeille Mohamed; Gérard Kpanidja; Moutawakilou Gomina; François Hounsou; Basile G Aouanou; Catherine Okoi; Claire Oluwalana; Archibald Worwui; Peter S Ndow; Jean Nounagnon; Jason M Mwenda; Rock A Sossou; Brenda A Kwambana-Adams; Martin Antonio Journal: Clin Infect Dis Date: 2019-09-05 Impact factor: 9.079